R75.00 ($0.05)

+1.00 (+1.35%)

Weekly Expected Move ±13.8%

R54 R64 R74 R84 R94

JNB · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 49 · R605.8M mcap · 70M float · 0.100% daily turnover

Analysis Technicals Weather Peers

Revenue

$8.5B -3.3% ▼

5Y CAGR: +5.7%

Gross Profit

$4.9B +35.2% ▲

5Y CAGR: +0.0%

Operating Income

$675M +22.7% ▲

5Y CAGR: +0.4%

Net Income

-$29M -152.0% ▼

EPS (Diluted)

$-0.31 -569.0% ▼

EBITDA

$578M -11.4% ▼

5Y CAGR: -10.1%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$8.1B	$8.7B	$8.8B	$8.8B	$8.5B
YoY Growth	+25.4%	+8.0%	+0.4%	+0.4%	-3.3%
Cost of Revenue	$2.0B	$2.3B	$4.2B	$5.1B	$3.6B
Gross Profit	$3.6B	$6.4B	$4.8B	$3.7B	$4.9B
Gross Margin	44.0%	73.9%	54.6%	41.5%	58.1%
R&D Expenses	$87M	$112M	$119M	$115M	$0
SG&A Expenses	$141M	$229M	$343M	$320M	$329M
Operating Expenses	$2.7B	$341M	$3.2B	$3.1B	$4.3B
Operating Income	$775M	$734M	$3.6B	$550M	$675M
Operating Margin	9.6%	8.4%	41.6%	6.3%	7.9%
Interest Expense	$57M	$76M	$94M	$96M	$81M
Income Before Tax	$700M	$675M	$427M	$207M	$105M
Tax Expense	$206M	$191M	$132M	$133M	$116M
Net Income	$302M	$313M	$184M	$55M	-$29M
Net Margin	3.7%	3.6%	2.1%	0.6%	-0.3%
EPS (Diluted)	$0.51	$0.53	$0.30	$0.07	$-0.31
EBITDA	$1.1B	$1.1B	$865M	$652M	$578M
Shares Outstanding	590M	594M	610M	837M	816M

Line Item	FY2021 Q2	FY2021 Q4	FY2022 Q2	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4
Revenue	$4.3B	$4.4B	$4.3B	$4.5B	$4.4B	$4.5B	$4.3B	$4.3B
Cost of Revenue	$3.7B	$1.3B	$2.4B	$2.6B	$2.5B	$2.6B	$2.4B	$2.3B
Gross Profit	$563M	$3.1B	$2.0B	$1.9B	$1.9B	$1.9B	$1.9B	$1.9B
Gross Margin	13.1%	70.8%	45.3%	41.9%	43.1%	42.7%	44.3%	45.2%
R&D Expenses	$0	$56M	$0	$60M	$0	$115M	$63M	$0
SG&A Expenses	$251M	$2.7B	$1.7B	$1.7B	$1.6B	$142M	$267M	$261M
Operating Expenses	$251M	$2.7B	$1.7B	$1.7B	$1.6B	$257M	$331M	$261M
Operating Income	$312M	$412M	$296M	$209M	$293M	$1.7B	$1.6B	$1.7B
Operating Margin	7.3%	9.3%	6.8%	4.6%	6.7%	37.0%	36.6%	39.1%
Interest Expense	$15M	$16M	$44M	$50M	$48M	$48M	$17M	$36M
Income Before Tax	$319M	$349M	$266M	$147M	$260M	-$55M	-$56M	$161M
Tax Expense	$90M	$103M	$77M	$55M	$77M	$56M	$63M	$53M
Net Income	$154M	$160M	$126M	$57M	$174M	-$118M	-$126M	$97M
Net Margin	3.6%	3.6%	2.9%	1.3%	4.0%	-2.6%	-2.9%	2.3%
EPS (Diluted)	$0.26	$0.27	$0.21	$0.09	$0.21	$-0.14	$-0.15	$0.12
EBITDA	$538M	$624M	$492M	$372M	$479M	$1.2B	$1.1B	$1.1B
Shares Outstanding	595M	597M	589M	660M	835M	837M	841M	864M

ACT.JO JNB